1087659-32-2

Basic information

• Product Name: (5-Bromo-3-methoxypyridin-2-yl)methanol
• Synonyms: (5-Bromo-3-methoxypyridin-2-yl)methanol
• CAS NO: 1087659-32-2
• Molecular Formula: C7H8BrNO2
• Molecular Weight: 218.04792
• Mol File: 1087659-32-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 289.2±35.0 °C(Predicted)
• Appearance: /
• Density: 1.595±0.06 g/cm3(Predicted)
• PKA: 12.61±0.10(Predicted)
• CAS DataBase Reference: (5-Bromo-3-methoxypyridin-2-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (5-Bromo-3-methoxypyridin-2-yl)methanol(1087659-32-2)
• EPA Substance Registry System: (5-Bromo-3-methoxypyridin-2-yl)methanol(1087659-32-2)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 1087659-32-2(Hazardous Substances Data)

Usage

Description

(5-Bromo-3-methoxypyridin-2-yl)methanol is a chemical compound with the molecular formula C7H8BrNO2. It is a derivative of pyridine, featuring a bromine atom and a methoxy group. This white to off-white solid is commonly utilized as an intermediate in the synthesis of pharmaceuticals and organic compounds. Its structural attributes, including the bromine and methoxy groups, render it a versatile building block with potential applications across various chemical processes and industries.

Uses

Used in Pharmaceutical Synthesis:
(5-Bromo-3-methoxypyridin-2-yl)methanol is used as an intermediate in the pharmaceutical industry for the synthesis of various medicinal compounds. Its unique structure allows for the creation of new drugs with specific therapeutic properties.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, (5-Bromo-3-methoxypyridin-2-yl)methanol is used as a building block for the synthesis of a range of organic compounds. Its presence of bromine and methoxy groups provides a foundation for further chemical reactions and modifications.
Used in Chemical Research:
(5-Bromo-3-methoxypyridin-2-yl)methanol is also utilized in chemical research as a model compound to study various reaction mechanisms and to develop new synthetic methodologies. Its reactivity and structural features make it a valuable tool for advancing scientific understanding in chemistry.

Upstream product

• 1087659-24-2 5-bromo-3-methoxypicolinaldehyde 
• 1142191-66-9 5-bromo-3-methoxy-pyridine-2-carboxylic acid 
• 1142192-55-9 methyl 5-bromo-3-methoxvpicolinate 

Downstream Products

• 1087659-24-2 5-bromo-3-methoxypicolinaldehyde 
• 1138443-85-2 5-bromo-2-(((tert-butyldimethylsilyl)oxy)methyl)-3-methoxypyridine 

Relevant articles and documents

CYCLOALKANE-1,3-DIAMINE DERIVATIVE

The present invention provides a compound or a pharmaceutically acceptable salt thereof having an inhibitory action on the interaction between menin and an MLL protein. The compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. wherein, in the formula (1), the dotted circle, R1, R2, R3, R4, R5, R6, R7, R8, Ring Q1, W, m and n are each as defined in the description.

N-(2-(4-((1R,3R)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENOXY)ETHYL)PROPAN-1-AMINE DERIVATIVES AND RELATED COMPOUNDS AS SELECTIVE DOWN-REGULATORS OF THE ESTROGEN RECEPTOR FOR TREATING CANCER

The specification relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, pharmaceutical compositions containing them and to the compounds of Formula (I) for use as selective down-regulators of the estrogen receptor in the treatment of cell proliferative disorders, such as cancer.

1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

The invention relates to the use of 1 H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1 H-imidazo[4,5-c]quinolinone compounds.